Search
forResearch 10 of 214
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up
- Resolution of experimental malaria-associated acute respiratory distress syndrome is Alox12 independent and shows residual inflammation
- The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019
- COVID-19 clinical outcomes and nationality: results from a Nationwide registry in Kuwait
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- COVID-19 Clinical Outcomes and Nationality: Results from a Nationwide Registry in Kuwait
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- Role of ACE2 polymorphism in COVID-19: impact of age
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →